- Made in the Womb: Maternal Programming of Offspring Cardiovascular Function by an Obesogenic Womb
Metabolites · 2023
- Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
TH Open · 2023
- Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin
Heart Views · 2023
- Preventive Effects of Nicorandil and Atorvastatin in Contrastinduced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Artery Angiography: A Double Blind, Randomized, Controlled Clinical Trial.
2023
- Efficacy of topical atorvastatin‐loaded emulgel and nano‐emulgel 1% on post‐laparotomy pain and wound healing: A randomized double‐blind placebo‐controlled clinical trial
International Wound Journal · 2023
- Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain
Revista Clínica Española (English Edition) · 2023
- Apixaban drug level monitoring in hemodialysis
2023
- Evaluation of the Effects of Atorvastatin and N-Acetyl Cysteine on Platelet Counts in Patients with Primary Immune Thrombocytopenia: An Exploratory Clinical Trial
Medicina · 2023
- Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke
Medicine · 2023
- Apixaban and Clopidogrel in a fixed-dose combination: Formulation and in vitro evaluation
2023
- Bioequivalence study of two formulations of rivaroxaban in healthy adult subjects under fasting conditions
American Journal of Pharmacotherapy and Pharmaceutical Sciences · 2023
- Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
Journal of International Medical Research · 2023
- The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF)
Frontiers in Cardiovascular Medicine · 2023
- Clinical and pharmacological approaches to personalization of the prescription of oral anticoagulants: clinical cases
Meditsinskiy sovet = Medical Council · 2023
- Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
Frontiers in Pharmacology · 2023
- Spontaneous Hemothorax caused by Rivaroxaban treatment for pulmonary embolism
2023
- Pharmacokinetics of Apixaban Among Peritoneal Dialysis Patients
Kidney Medicine · 2023
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia
Cardiovascular Drugs and Therapy · 2023
- Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial
BMJ Open · 2023
- Efficacy and Safety of Rivaroxaban in Prevention and Therapy of Thromboembolic Events in Patients with Nonvalvular Atrial Fibrillation
Journal of the Practice of Cardiovascular Sciences · 2023
- PERBANDINGAN EFEKTIVITAS RIVAROXABAN DAN WARFARIN DALAM MENGATASI KEJADIAN EMBOLI PADA PASIEN DENGAN ATRIAL FIBRILASI
Jurnal Ners · 2023
- Low-dose rivaroxaban: can cardiovascular events be reduced?
European Heart Journal Supplements · 2023
- Risk Factors of Upper Extremity Deep Vein Thrombosis After Pacemaker Implantation
Journal of Venous Disorders · 2023
- Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countries
2023
- Efficacy and safety of direct oral anticoagulants in children in real clinical practice
Russian Journal of Pediatric Hematology and Oncology · 2023
- Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
Medicina · 2023
- Evaluation of the Inappropriate Prescribing Practices of Rivaroxaban and Their Association with Bleeding in Tertiary Care Hospitals in Saudi Arabia
Saudi Journal of Clinical Pharmacy · 2023
- Effect of new cardiac rehabilitation mode on cardiac function, mental state and quality of life of postoperative patients with acute myocardial infarction treated with atorvastatin calcium tablet.
2023
- Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran
Medical Journal of the Islamic Republic of Iran · 2023
- Pseudo‑Wellens syndrome in an elderly female patient with pulmonary embolism: A case report
Medicine International · 2023
- Non Vitamin k Antagonist Oral Anticoagulation Assessment in Non Valvular Atrial Fibrillation Using Transcranial Doppler Ultrasonography
Clinical Neurology and Neuroscience · 2023
- Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway
BMC Medicine · 2023
- Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
Circulation Reports · 2023
- Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
Biomedicines · 2023
- Influence of Loading Dose Of Atorvastatin on the Risk of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction
Kardiologiia · 2023
- The Efficacy and Safety of Direct Oral Anticoagulants for The Treatment of Venous Thrombosis in Cancer Using Fuzzy PROMETHEE
2023
- Therapeutic effects of atorvastatin on doxorubicin‐induced hepatotoxicity in rats via antioxidative damage, anti‐inflammatory, and anti‐lipotoxicity
Journal of Biochemical and Molecular Toxicology · 2023
- Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations
Pharmaceutics · 2023
- The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts—A Retrospective Single-Center Cohort Study
International Journal of Environmental Research and Public Health · 2023
- Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats
Molecules · 2023
- A Practical Statin Recommendation System Based on Real-World Data to Improve LDL-C Management in Secondary Prevention
Journal of Cardiovascular Pharmacology · 2023
- Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
Pharmaceutics · 2023
- Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis
Frontiers in Cardiovascular Medicine · 2023
- INVICTUS: Vitamin K antagonists remain the standard of care for rheumatic heart disease-associated atrial fibrillation
Global Cardiology Science and Practice · 2023
- The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty
Journal of Clinical Medicine · 2023
- Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites
Drug Design Development and Therapy · 2023
- Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?
Journal of Clinical Medicine · 2023
- Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis
Frontiers in Cardiovascular Medicine · 2023
- Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients
Journal of Stroke · 2023
- Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study
International Journal of General Medicine · 2023